Skip to main content
Erschienen in: Rheumatology International 5/2012

01.05.2012 | Short Communication

Effect of biofeedback and deep oscillation on Raynaud’s phenomenon secondary to systemic sclerosis: results of a controlled prospective randomized clinical trial

verfasst von: Birte Sporbeck, Kirsten Mathiske-Schmidt, Silke Jahr, Dörte Huscher, Mike Becker, Gabriela Riemekasten, Ines Taufmann, Gerd-Rüdiger Burmester, Stephanie Pögel, Anett Reisshauer

Erschienen in: Rheumatology International | Ausgabe 5/2012

Einloggen, um Zugang zu erhalten

Abstract

Our aim was to evaluate the effect of deep oscillation and biofeedback on Raynaud’s phenomenon (RP) secondary to systemic sclerosis (SSc). A prospective randomized study was performed in SSc patients receiving either deep oscillation (n = 10) or biofeedback (n = 8) thrice a week for 4 weeks, or patients were randomized into the waiting group untreated for vasculopathy (n = 10) in time of running the study interventions. Biofeedback resulted in an improvement of RP as determined by score reduction of visual analogue scale compared with patients of the control group (P < 0.05), whereas deep oscillation revealed a tendency for improvement (P = 0.055). The study underlines the beneficial role of physiotherapy for the treatment of SSc-related RP.
Literatur
1.
Zurück zum Zitat LeRoy EC (1996) Systemic sclerosis. A vascular perspective. Rheum Dis Clin North Am 22(4):675–694PubMedCrossRef LeRoy EC (1996) Systemic sclerosis. A vascular perspective. Rheum Dis Clin North Am 22(4):675–694PubMedCrossRef
2.
Zurück zum Zitat Sunderkotter C, Riemekasten G (2006) Pathophysiology and clinical consequences of Raynaud’s phenomenon related to systemic sclerosis. Rheumatology (Oxford) 45(Suppl 3):iii33–iii35CrossRef Sunderkotter C, Riemekasten G (2006) Pathophysiology and clinical consequences of Raynaud’s phenomenon related to systemic sclerosis. Rheumatology (Oxford) 45(Suppl 3):iii33–iii35CrossRef
3.
Zurück zum Zitat Riemekasten G, Sunderkotter C (2006) Vasoactive therapies in systemic sclerosis. Rheumatology (Oxford) 45(Suppl 3):iii49–iii51CrossRef Riemekasten G, Sunderkotter C (2006) Vasoactive therapies in systemic sclerosis. Rheumatology (Oxford) 45(Suppl 3):iii49–iii51CrossRef
4.
Zurück zum Zitat Foerster J, Fleischanderl S, Wittstock S, Storch A, Meffert H, Riemekasten G, Worm M (2005) Infrared-mediated hyperthermia is effective in the treatment of scleroderma-associated Raynaud’s phenomenon. J Invest Dermatol 125(6):1313–1316PubMedCrossRef Foerster J, Fleischanderl S, Wittstock S, Storch A, Meffert H, Riemekasten G, Worm M (2005) Infrared-mediated hyperthermia is effective in the treatment of scleroderma-associated Raynaud’s phenomenon. J Invest Dermatol 125(6):1313–1316PubMedCrossRef
5.
Zurück zum Zitat Jahr S, Schoppe B, Reisshauer A (2008) Effect of treatment with low-intensity and extremely low-frequency electrostatic fields (Deep Oscillation) on breast tissue and pain in patients with secondary breast lymphoedema. J Rehabil Med 40(8):645–650PubMedCrossRef Jahr S, Schoppe B, Reisshauer A (2008) Effect of treatment with low-intensity and extremely low-frequency electrostatic fields (Deep Oscillation) on breast tissue and pain in patients with secondary breast lymphoedema. J Rehabil Med 40(8):645–650PubMedCrossRef
6.
Zurück zum Zitat Yocum DE, Hodes R, Sundstrom WR, Cleeland CS (1985) Use of biofeedback training in treatment of Raynaud’s disease and phenomenon. J Rheumatol 12(1):90–93PubMed Yocum DE, Hodes R, Sundstrom WR, Cleeland CS (1985) Use of biofeedback training in treatment of Raynaud’s disease and phenomenon. J Rheumatol 12(1):90–93PubMed
7.
Zurück zum Zitat Wilson E, Belar CD, Panush RS, Ettinger MP (1983) Marked digital skin temperature increase mediated by thermal biofeedback in advanced scleroderma. J Rheumatol 10(1):167–168PubMed Wilson E, Belar CD, Panush RS, Ettinger MP (1983) Marked digital skin temperature increase mediated by thermal biofeedback in advanced scleroderma. J Rheumatol 10(1):167–168PubMed
8.
Zurück zum Zitat Freedman RR, Ianni P, Wenig P (1984) Behavioral treatment of Raynaud’s phenomenon in scleroderma. J Behav Med 7(4):343–353PubMedCrossRef Freedman RR, Ianni P, Wenig P (1984) Behavioral treatment of Raynaud’s phenomenon in scleroderma. J Behav Med 7(4):343–353PubMedCrossRef
9.
Zurück zum Zitat Malenfant D, Catton M, Pope JE (2009) The efficacy of complementary and alternative medicine in the treatment of Raynaud’s phenomenon: a literature review and meta-analysis. Rheumatology (Oxford) 48(7):791–795 Epub 2009 May 11CrossRef Malenfant D, Catton M, Pope JE (2009) The efficacy of complementary and alternative medicine in the treatment of Raynaud’s phenomenon: a literature review and meta-analysis. Rheumatology (Oxford) 48(7):791–795 Epub 2009 May 11CrossRef
Metadaten
Titel
Effect of biofeedback and deep oscillation on Raynaud’s phenomenon secondary to systemic sclerosis: results of a controlled prospective randomized clinical trial
verfasst von
Birte Sporbeck
Kirsten Mathiske-Schmidt
Silke Jahr
Dörte Huscher
Mike Becker
Gabriela Riemekasten
Ines Taufmann
Gerd-Rüdiger Burmester
Stephanie Pögel
Anett Reisshauer
Publikationsdatum
01.05.2012
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 5/2012
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-011-1882-2

Weitere Artikel der Ausgabe 5/2012

Rheumatology International 5/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.